Study summary

The purpose of the study is to evaluate the analgesic efficacy of ASP7962 relative to placebo.

This study will also evaluate the efficacy of ASP7962 relative to placebo on pain on walking, function and stiffness; the time course of efficacy of ASP7962 relative to placebo; the improvement in overall patient status of ASP7962 relative to placebo as well as the safety and tolerability of ASP7962 relative to placebo.

Additional Study Details

Phase
2
Product
  • ASP7962
  • Naproxen
  • Placebo
  • Type
    Interventional
    Masking
    Triple (Participant, Investigator, Outcomes Assessor)
    Enrollment number
    215
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Analgesic Efficacy of ASP7962 in Patients with Pain Due to Osteoarthritis of the Knee? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site ES34004
      Santiago de Compostela, Spain, 15702
      Completed
      Site HU36006
      Debrecen, Hungary, 4032
      Completed
      Site ES34002
      A Coruna, Spain, 15006
      Completed
      Site DE49003
      Leipzig, Germany, 4108
      Completed
      Site DE49007
      Bayern, Germany, 80639
      Terminated
      Site HU36003
      Komarom, Hungary, 2900
      Completed
      Site HU36002
      Baja, Hungary, 6500
      Completed
      Site ES34012
      Barcelona, Spain, 8034
      Completed
      Site CZ42005
      Praha 4, Czech Republic, 14059
      Completed
      Site HU36008
      Balatonfured, Hungary, 8230
      Withdrawn
      Site BE32005
      Liege, Belgium, 4020
      Completed
      Site DE49006
      Berlin, Germany, 10629
      Completed
      Site HU36004
      Veszprem, Hungary, 8200
      Completed
      Site HU36001
      Esztergom, Hungary, 2500
      Completed
      Site BE32003
      Leuven, Belgium, 3000
      Completed
      Site BE32004
      Yvoir, Belgium, 5530
      Completed
      Site HU36005
      Bekescsaba, Hungary, 5600
      Completed
      Site ES34001
      Barakaldo, Spain, 48903
      Completed
      Site CZ42003
      Kunovice, Czech Republic, 686 04
      Completed
      Site GB44011
      North Shields, United Kingdom, NE29 8NH
      Completed
      Site GB44006
      London, United Kingdom, NW3 2QG
      Completed
      Site CZ42002
      Praha 4, Czech Republic, 14000
      Completed
      Site GB44010
      Oxfordshire, United Kingdom, OX3 7LD
      Completed
      Site ES34005
      Madrid, Spain, 28046
      Completed
      Site BE32002
      Merksem, Belgium, 2170
      Completed
      Site ES34008
      Barcelona, Spain, 8028
      Completed
      Site ES34003
      Bilbao, Spain, 48013
      Completed
      Site HU36009
      Szeged, Hungary, 6722
      Completed
      Site GB44012
      West Midlands, United Kingdom, WS11 5XY
      Withdrawn
      Site GB44004
      London, United Kingdom, SW17 0QT
      Completed
      Site ES34010
      Valencia, Spain, 46015
      Completed
      Site CZ42006
      Hradec Kralove, Czech Republic, 50341
      Completed
      Site DE49005
      Munich, Germany, 80809
      Completed
      Site DE49004
      Deggingen, Germany, 73326
      Completed
      Site DE49001
      Magdeburg, Germany, 39120
      Withdrawn
      Site GB44001
      Cambridge, United Kingdom, CB2 2QQ
      Completed
      Site HU36007
      Budapest, Hungary, 1027

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?